Christopher McNulty

Business address
C/O Invivo Therapeutics Holdings Corp., 1 Kendall Square, Suite B14402, Cambridge, MA, 02139
Top holdings (ownership)
VBIV
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Christopher McNulty has filed 11 SEC EDGAR filings since 31 Mar 2017

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 30 Jan 2023 26 Jan 2023 001-37769
4 Open Document Open Filing 31 Jan 2022 27 Jan 2022 001-37769
4 Open Document Open Filing 29 Jan 2021 27 Jan 2021 001-37769
4 Open Document Open Filing 02 Jul 2020 01 Jul 2020 001-37769
4 Open Document Open Filing 24 Jan 2020 22 Jan 2020 001-37769
4 Open Document Open Filing 01 Oct 2019 01 Oct 2019 001-37769
4 Open Document Open Filing 04 Feb 2019 31 Jan 2019 001-37769
4 Open Document Open Filing 21 Sep 2018 19 Sep 2018 001-37769
3 Open Document Open Filing 20 Aug 2018 14 Aug 2018 001-37769
4 Open Document Open Filing FORM 4 - 31 Mar 2017 29 Mar 2017 001-37350
3 Open Document Open Filing FORM 3 - 31 Mar 2017 29 Mar 2017 001-37350